Mobile

A Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Study to Assess the Safety and Efficacy of Doripenem Compared With Imipenem-Cilastatin in the Treatment of Subjects with Ventilator-A...

Mise à jour : Il y a 4 ans
Référence : EUCTR2007-004646-33

A Prospective, Randomized, Double-Blind, Double-Dummy, Multicenter Study to Assess the Safety and Efficacy of Doripenem Compared With Imipenem-Cilastatin in the Treatment of Subjects with Ventilator-Associated Pneumonia

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to demonstrate the noninferiority of a 7-day course of doripenem to a 10-day course of imipenem-cilastatin with respect to the clinical cure rate at the EOT visit in clinically evaluable subjects with VAP.

Critère d'inclusion

  • Ventilator associated pneumonia

Liens